| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 69753-59-9 | 無 | 詳情 | 供應商 | |||
| 69022-75-9 | 2-Methyl-3-(2-propenyloxy)pyridine |  | C9H11NO | 詳情 | 供應商 | |
| 13879-71-5 | 無 | 詳情 | 供應商 | |||
| 945595-80-2 | AMG 900 | AMG 900 | 無 | 詳情 | 供應商 | |
| 918505-84-7 | N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺; N-[3-[(5-氯-1H-吡咯并[2,3-B]吡? | N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide; N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide; PLX-4720; N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide |  | C17H14ClF2N3O3S | 詳情 | 供應商 |
| 918504-65-1 | 維羅非尼; 維羅非尼 | N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaM | 無 | C23H18ClF2N3O3S | 詳情 | 供應商 |
| 700874-72-2 | LY 2157299 | LY 2157299 | 無 | 詳情 | 供應商 | |
| 780757-88-2 | ICG-001; ICG001; (6S,9AS)-6-(4-HYDROXYBENZYL)-N-BENZYL-8-(NAPHTHALEN-1-YLMETHYL)-4,7-DIOXO-HEXAHYDRO-2 | 2H-PYRAZINO[1,2-A]PYRIMIDINE-1(6H)-CARBOXAMIDE,HEXAHYDRO-6-[(4-HYDROXYPHENYL)METHYL]-8-(1-NAPHTHALEN; 2H-PYRAZINO[1,2-A]PYRIMIDINE-1(6H)-CARBOXAMIDE,HEXAHYDRO-6-[(4-HYDROXYPHENYL)METHYL]-8-(1-NAPHTHALENYLMETHYL)-4,7-DIOXO-N-(PHENYLMETHYL)-,(6R,9AR)-REL-; (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide; (6S,9aS)-6-(4-hydroxybenzyl)-N-benzyl-8-(naphthalen-1-ylmethyl)-4,7-dioxo-hexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide; (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylMethyl)-; (6S,9AS)-6-(4-HYDROXYBENZYL)-8-NAPHTHALEN-1-YLMETHYL-4,7-DIOXO-HEXAHYDRO-PYRAZINO[1,2-A]PYRIMIDINE-1-CARBOXYLIC ACID BENZYLAMIDE |  | C33H32N4O4 | 詳情 | 供應商 |
| 849217-68-1 | CABOZANTINIB; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-環(huán)丙烷二甲酰胺 | N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; Cabozantinib; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL184; Cabozantinib(XL184) |  | C28H24FN3O5 | 詳情 | 供應商 |
| 934541-31-8 | 無 | 詳情 | 供應商 | |||
| 475108-18-0 | N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-異惡唑基)脲; N-[2-氯-4-[(6,7-二甲氧基-4-喹? | N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; AV951; AV-951; Tivozanib; AV-951(Tivozanib); 1-(2-Chloro-4-(6,7-diMethoxyquinolin-4-yloxy)phenyl)-3-(5-Methylisoxazol-3-yl)urea |  | C22H19ClN4O5 | 詳情 | 供應商 |
| 1051375-16-6 | GSK1349572; (4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氫-7-羥基-4-甲基-6,8-二氧代-2H-吡啶并[1 | GSK1349572; GSK1349572; (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 無 | C20H19F2N3O5 | 詳情 | 供應商 |
| 471905-41-6 | 順式-4-[(4-氯苯基)磺�；鵠-4-(2,5-二氟苯基)環(huán)己烷丙酸; 順式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)環(huán)己? | cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid |  | C21H21ClF2O4S | 詳情 | 供應商 |
| 1144068-46-1 | N-[4-[1-(1,4-二氧雜螺[4.5]癸烷-8-基)-4-(8-氧雜-3-氮雜雙環(huán)[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基 | N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimi; N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea; WYE 125132 |  | C27H33N7O4 | 詳情 | 供應商 |
| 761439-42-3 | 5-氯-N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺�；鵠苯基]-2,4-嘧啶二胺 | NVP-TAE684 - TAE 684; NVP-TAE684 - TAE 684; 5-Chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-2,4-pyrimidinediamine; NVP-TAE 684; 2,4-Pyrimidinediamine, 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]- |  | C30H40ClN7O3S | 詳情 | 供應商 |
| 1229236-86-5 | LY 2784544; 3-[(4-氯-2-氟苯基)甲基]-2-甲基-N-(5-甲基-1H-吡唑-3-基)-8-(4-嗎啉甲基)咪唑并[1,2-B]噠嗪-6- | LY 2784544; LY 2784544; 3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine | 無 | C23H25ClFN7O | 詳情 | 供應商 |
| 847925-91-1 | RO4929097 | 無 | 詳情 | 供應商 | ||
| 935881-37-1 | AR-42; (S)-(+)-N-羥基-4-(3-甲基-2-苯基丁酰氨基)苯甲酰胺 | AR-42; AR-42; (S)-HDAC-42,AR-42; (S)-(+)-N-Hydroxy-4-(3-methyl-2-phenyl-butyrylamino)benzamide; (S)-HDAC 42 | 無 | C18H20N2O3 | 詳情 | 供應商 |
| 1226056-71-8 | THIAZOVIVIN; N-芐基-2-(嘧啶-4-基氨基)噻唑-4-甲酰胺 | Thiazovivin; N-Benzyl-2-(pyrimidin-4-ylamino)thiazole-4-carboxamide; Thiazovivin; N-(Phenylmethyl)-2-(4-pyrimidinylamino)-4-thiazolecarboxamide | 無 | C15H13N5OS | 詳情 | 供應商 |
| 717907-75-0 | N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氫-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰 | N-Methyl-N-[3-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]me; N-Methyl-N-[3-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide; PF-00562271; PF 562271; N-Methyl-N-(3-((2-(2-oxoindolin-5-ylaMino)-5-(trifluoroMethyl)pyriMidin-4-ylaMino)Methyl)pyridin-2-yl)MethanesulfonaMide |  | C21H20F3N7O3S | 詳情 | 供應商 |